Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 105   

Articles published

4502 4,546.00 +18.00 (0.40%)
price chart
Stocks In News: Takeda Pharmaceutical Co (OTCMKTS:TKPYY), Hooper ...
Ltd (ADR) (OTCMKTS:TKPYY) lost the first federal court trial in the U.S. over claims it hid the cancer risks of its Actos diabetes medicine to protect billions of dollars in sales.
Related articles »  
Takeda Pharmaceutical Co.'s share price down, sentenced to pay 6 billion ...
Takeda Pharmaceutical Co. Ltd, the largest drug manufacturer by revenue in Japan, was imposed a 6-billion dollar fine by a U.S.
Jury smacks Takeda, Eli Lilly with $9B verdict over Actos drug  Seeking Alpha
Takeda, Lilly Jury Awards $9 Billion Over Actos Risks  Bloomberg
Related articles »  
Narrower of Possible Claim Constructions Prevails - Takeda Pharmaceutical Co ...
Takeda Pharmaceutical Co. Ltd. v. Zydus Pharma USA, Inc., Case No. 13-1406 (Fed. Cir., Feb. 20, 2014) (Prost, J.). Takeda Pharmaceutical and several related entities own patents claiming the formulation for the brand-name drug Prevacid´┐Ż SolutabTM, ...
Jury slaps Takeda with $6B in damages for concealing cancer risk
TOKYO (Reuters) - Shares in Takeda Pharmaceutical Co Ltd <4502.T> were down nearly 6 percent on Tuesday morning after Bloomberg news reported that a U.S.
Takeda Pharma says Japan approves two flu vaccine drugs
TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd said on Monday it had received approval to manufacture and supply two vaccines for prevention of pandemic influenza from the Japanese health ministry.
Related articles »  
Dainippon Sumitomo Pharma and Takeda Announce the European Marketing ...
Dainippon Sumitomo Pharma Co., Ltd. ("DSP") (Head Office: Osaka, Japan) and Takeda Pharmaceutical Company Limited ("Takeda") (Head Office: Osaka, Japan) today jointly announced that the European Commission has granted Marketing Authorization ...
Takeda, Dainippon Sumitomo Get Schizophrenia Drug Approval Europe  Drug Discovery & Development
Related articles »  
Stocks Roundup - Ferrellgas Partners, L.P. (FGP), Aviva Plc (ADR) (AV), Takeda ...
Otsuka Pharmaceutical Co. Ltd and Takeda Pharmaceutical Co. Ltd. (TKPYY) have signed into a co-promotion agreement in Japan for TAK-438, a drug discovered by Takeda for the treatment of acid-related diseases, the two Japanese drugmakers said late ...
AAW Pharmaceuticals partners with global pharmaceutical leader "Takeda"
(AAW) today announced a partnership agreement with Japan-based pharmaceutical company Takeda Pharmaceutical Company Limited (Takeda), the largest pharmaceutical company in Asia, to distribute a new and wide range of high-quality pharmaceutical ...
Otsuka, Takeda To Co-promote Gastrointestinal Drug TAK-438 In Japan
Otsuka Pharmaceutical Co. Ltd and Takeda Pharmaceutical Co. Ltd. (TKPYY) have entered into a co-promotion agreement in Japan for TAK-438, a drug discovered by Takeda for the treatment of acid-related diseases, the two Japanese drugmakers said late ...
Otsuka, Takeda Sign Co-promotion Deal For TAK-438 In Japan - Quick Facts  NASDAQ
Otsuka, Takeda sign co-promotion pact in Japan for TAK-438 to treat acid ...  pharmabiz.com
Related articles »  
Takeda, Otsuka to Co-Promote Gastrointestinal Drug in Japan
Takeda, Otsuka to Co-Promote Gastrointestinal Drug in Japan. Thu, 03/27/2014 - 5:26am. Takeda. Get today's drug discovery & development headlines and news - Sign up now!